Denosumab for Osteoporosis Treatment in Rheumatic Diseases: What Do We Know 15 Years Post Approval?
J Rheumatol
.
2025 Sep 1;52(9):855-857.
doi: 10.3899/jrheum.2025-0726.
Authors
Stanley B Cohen
1
,
Kenneth G Saag
2
Affiliations
1
S.B. Cohen, MD, UT Southwestern Medical School, and Rheumatology Division, THR Dallas Presbyterian, Dallas, Texas; Arthdoc@aol.com.
2
K.G. Saag, MD, MSc, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
PMID:
40750319
DOI:
10.3899/jrheum.2025-0726
No abstract available
Publication types
Editorial